CSS LLC’s Opus Genetics IRD Stock Holding History

CSS LLC’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-252	Closed	-$5.21M	–	796
2016 Q2	$5.21M	Buy	+252	New	+$35.3K	0.35%	62

Other funds holding IRD

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HVIA

Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

CSS LLC's IRD Position: Q3 2016 in Review

CSS LLC sold out of Opus Genetics (IRD) in Q3 2016, closing a stake of 252 shares — an estimated $5.21M sold.

CSS LLC first reported a position in IRD in Q2 2016 and held it in 1 quarter. The position peaked at $5.21M in Q2 2016. 33 funds tracked by Wall St. Rank hold IRD as of Q3 2016.

CSS LLC reported no remaining Opus Genetics position as of Q3 2016 after selling out during the quarter.
CSS LLC sold 252 Opus Genetics shares in Q3 2016, an estimated $5.21M.
CSS LLC first reported a position in Opus Genetics in Q2 2016 and held it in 1 quarter.
CSS LLC's Opus Genetics position peaked at $5.21M in Q2 2016.
33 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2016.

Based on CSS LLC's 13F filing for Q3 2016, filed 14 Nov 2016.